Thermal Biofeedback for the Treatment of Diabetic Neuropathy
Primary Purpose
Diabetic Neuropathy, Painful
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Thermal Biofeedback Assisted Relaxation
Discussion with therapist
Sponsored by
About this trial
This is an interventional treatment trial for Diabetic Neuropathy, Painful focused on measuring Diabetes, Neuropathy, Peripheral, Painful, Thermal, Temperature, Biofeedback, Relaxation, Diabetic
Eligibility Criteria
Inclusion Criteria:
- Clinical Diagnosis of Diabetic Neuropathy in Hands and/or Feet
- Must have some sensation left in hands and feet
Exclusion Criteria:
- Any partial or total amputation of an limb or digit
- Any previous experience with biofeedback
- Prior treatment for alcohol abuse
- Severe Psychopathology
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Thermal Biofeedback Assisted Relaxation
Discussion
Arm Description
Outcomes
Primary Outcome Measures
Subjective Pain
Secondary Outcome Measures
Perceived Control
Temperature
Full Information
NCT ID
NCT00858351
First Posted
March 6, 2009
Last Updated
August 30, 2021
Sponsor
Northwestern University
Collaborators
Insulin Dependent Diabetes Trust, American Pain Society, Rosalind Franklin University of Medicine and Science
1. Study Identification
Unique Protocol Identification Number
NCT00858351
Brief Title
Thermal Biofeedback for the Treatment of Diabetic Neuropathy
Official Title
A Placebo-Controlled Trial of Thermal Biofeedback Assisted Relaxation for the Treatment of Diabetic Neuropathy: An Evaluation of Outcomes and Mechanisms
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
October 2011 (Actual)
Study Completion Date
April 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Northwestern University
Collaborators
Insulin Dependent Diabetes Trust, American Pain Society, Rosalind Franklin University of Medicine and Science
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to examine potential treatment options for a condition in diabetics that causes tingling, pain, and numbness in the hands and /or feet, also known as diabetic peripheral neuropathy.
Detailed Description
Participants attend 6 sessions lasting from 35 minutes to 2 hours (depending on the session). Sessions can be scheduled once or twice per week. Sessions involve a walking task, filling out questionnaires, and having temperature of hands and feet monitored. This study involves no drugs, blood draws, or any other invasive procedures. Participants are urged to continue the treatment of diabetes and diabetic neuropathy as directed by their physician for the duration of their involvement with the study. After 3 months, a packet of questionnaires will be mailed with a stamped addressed envelope to be returned.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Neuropathy, Painful
Keywords
Diabetes, Neuropathy, Peripheral, Painful, Thermal, Temperature, Biofeedback, Relaxation, Diabetic
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Thermal Biofeedback Assisted Relaxation
Arm Type
Experimental
Arm Title
Discussion
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Thermal Biofeedback Assisted Relaxation
Intervention Description
6 sessions, 25 minutes in duration of relaxation and imagery training while temperature of hands and feet are recorded.
Intervention Type
Behavioral
Intervention Name(s)
Discussion with therapist
Intervention Description
6 sessions, 25 minutes each, discussing topics with a therapist.
Primary Outcome Measure Information:
Title
Subjective Pain
Time Frame
Change in subjective pain rating from baseline to end of intervention
Secondary Outcome Measure Information:
Title
Perceived Control
Time Frame
Change from mid-intervention (visit 4) to end of intervention
Title
Temperature
Time Frame
Change within each session and across sessions from baseline to end of intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical Diagnosis of Diabetic Neuropathy in Hands and/or Feet
Must have some sensation left in hands and feet
Exclusion Criteria:
Any partial or total amputation of an limb or digit
Any previous experience with biofeedback
Prior treatment for alcohol abuse
Severe Psychopathology
12. IPD Sharing Statement
Learn more about this trial
Thermal Biofeedback for the Treatment of Diabetic Neuropathy
We'll reach out to this number within 24 hrs